https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3ABiosimilar%2F7%2FenTranslations:Biosimilar/7/en - Revision history2026-07-12T21:04:13ZRevision history for this page on the wikiMediaWiki 1.43.0https://wiki.tiffa.net/w/index.php?title=Translations:Biosimilar/7/en&diff=130316&oldid=prevFuzzyBot: Importing a new version from external source2024-03-20T00:54:06Z<p>Importing a new version from external source</p>
<p><b>New page</b></p><div>===United States===<br />
In the United States, the [[Food and Drug Administration]] (FDA) held that new legislation was required to enable them to approve biosimilars to those biologics originally approved through the PHS Act pathway. Additional Congressional hearings have been held. On March 17, 2009, the Pathway for Biosimilars Act was introduced in the House. Since 2004 the FDA has held a series of public meetings on biosimilars.</div>FuzzyBot